ANTG is a proudly Australian, independently owned medicinal cannabis focused company.
We are motivated by the possibilities and health benefits that medicinal cannabis offers.
We combine a strong research focus with best in class cultivation and extraction systems to produce exclusive high quality cannabinoid-based medical treatments that can meet individual patient needs.
“Our pioneering approach is underpinned by deep expertise and a commitment to reduce suffering and improve people’s lives through the research, development and clinical application of cannabinoid-based medical treatments”
MATT CANTELO, ANTG CHIEF EXECUTIVE OFFICER.
In conjunction with the HMRI and lead biomedical scientist Dr Matt Dun, we’re investigating the anticancer properties of our plant varieties. Dr Matt Dun shares his initial thoughts on the joint research project.
One of ANTG’s proprietary medicinal cannabis strains, EVE Cannabis Indica, has been listed on the Australian Register of Therapeutic Goods (ARTG). The ARTG is a reference of therapeutic goods that can lawfully be supplied in or exported from Australia.
What’s most important in business – purpose or profit? At ANTG we get to achieve both.
We’re pleased to announce we have successfully passed the TGO93 and TGO100 mandatory tests for our first commercial export crop.
We are focused on research and development, partnering with leading scientists and medical institutions to develop cannabinoid medicines that offer safe and effective therapeutic benefits.
LEARN ABOUT ANTG HERE >
